Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
357
Frequently Asked Questions
What is Market Cap of Collegium Pharmaceutical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Collegium Pharmaceutical Inc market cap is $1.19B.
What is the 52-week high for Collegium Pharmaceutical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Collegium Pharmaceutical Inc 52 week high is $42.29 as of September 12, 2025.
What is the 52-week low for Collegium Pharmaceutical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Collegium Pharmaceutical Inc 52 week low is $23.23 as of September 12, 2025.
What is Collegium Pharmaceutical Inc stock price today?
Collegium Pharmaceutical Inc stock price today is $39.06.
What was Collegium Pharmaceutical Inc stock price yesterday?
Collegium Pharmaceutical Inc stock price yesterday was $37.71.
What is the PE ratio of Collegium Pharmaceutical Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Collegium Pharmaceutical Inc’s P/E ratio is 36.40.
What is the Price-to-Book ratio of Collegium Pharmaceutical Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Collegium Pharmaceutical Inc P/B ratio is 5.1236.
What is the 50-day moving average of Collegium Pharmaceutical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Collegium Pharmaceutical Inc 50-day moving average is $34.52.
How many employess does Collegium Pharmaceutical Inc has?